secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2026-08-31T21:15:01+00:00
Accession:  0001437749-26-029336
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech posts investor presentation; no material financial or clinical details disclosed
--------------------------------------------------------------------------------

- Corporate presentation dated August 31, 2026 published on company website.
- No revenue, earnings, clinical trial outcomes, or guidance figures provided in filing text.
- Materiality low; presentation content not reproduced in the 8-K submission.
- Ticker MBRX; presentation furnished under Regulation FD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926029336/0001437749-26-029336-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926029336/mbrx20260818_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-029336

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer